Cervix intraepithelial neoplasia (CIN), a precancerous lesion of invasive squamous carcinoma, can be classified histologically as CIN grades I to III. Not all CIN lesions progress to invasive cancer. In fact, most of the CIN I and II lesions spontaneously regress. However, factors that determine regression, persistence, or progression of CIN remain unknown. In this proposed prospective study, women with histopathologically diagnosed CIN I or II will be enrolled in a 12-month non-therapeutic follow-up study. The purpose is to identify biomarkers that predict spontaneous regression and persistence of cervix dysplasia. Defining biomarkers that modulate the biological process of CIN, the intermediate endpoint for invasive cancer, will provide valuable information on the carcinogenesis of cervix cancer. With a 12-month follow-up period, the emphasis of the study is not on progression, but rather on regression/persistence of CIN. Gaining insight about regression will have significant implications for understanding the natural history of the neoplasm as well as the prognosis and clinical management of women with CIN I or II. Women with histopathologically confirmed CIN I or II (N=465) will be recruited from the Bronx Municipal Hospital and the gynecology clinic of the Albert Einstein College of Medicine. They will be followed at 3-month intervals by Pap smear and colposcopy for 12 months. An endpoint biopsy will be performed at 12 months. The outcome of the study will be the presence (persistence) or absence (regression) of CIN lesion at 12 months. At each visit, cervico-vaginal lavage and a cervical swab sample will be collected for human papillomavirus (HPV) DNA analyses by both southern blot and polymerase chain reaction (PCR) techniques. Extracted DNA will also be used for typing of class II HLA-DQB1 and HLA-DRB1 alleles by PCR. Blood and urine samples as well as questionnaire data will be collected at baseline, 6, and 12 months. Plasma beta-carotene, ascorbic acid, and alpha-tocopherol levels will be measured by high pressure liquid chromatography methods, and red cell folate levels by Radioassay. The urinary ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone will be assessed by Enzyme Immunoassay. The questionnaire will collect information on demographic and behavioral factors. The study pathologist will review the initial and endpoint biopsy specimens, and the histologic characteristics of the lesion will be recorded. The association between regression/persistence of CIN and each of these biomarkers will first be examined in univariate analyses by chi-square, t test, and Wilcoxon rank sum test. Whether the outcome of CIN is influenced by interaction between HPV infection and another co-factor will be examined in stratification analyses. Finally, significant variables and interaction terms will be subjected to multiple logistic regression analysis where independent factors will be identified. ROC curve analysis will be used to examine the sensitivity and specificity of this model in discriminating women who will have regression versus women who will have persistent or progressive CIN.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064247-03
Application #
2330892
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1995-04-01
Project End
1999-01-31
Budget Start
1997-02-05
Budget End
1998-01-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Ho, Gloria Y F; Einstein, Mark H; Romney, Seymour L et al. (2011) Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting. J Low Genit Tract Dis 15:268-75
Ho, Gloria Y F; Xue, Xiao-Nan; Burk, Robert D et al. (2005) Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30:1-6
Ho, G Y F; Melman, A; Liu, S-M et al. (2003) Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer 88:263-9
Ho, Gloria Y F; Knapp, Michael; Freije, Diha et al. (2002) Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer families. Int J Cancer 98:938-42
Kadish, Anna S; Timmins, Patrick; Wang, Yuexian et al. (2002) Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 11:483-8
Qu, W; Jiang, G; Cruz, Y et al. (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304-10